ATLASAlto Neuroscience (ANRO) earnings date: Nov 11, 2026
Alto Neuroscience (ANRO) reports earnings for the quarter ended Sep 30, 2026 on Wed, Nov 11, 2026, after the close. Analysts expect EPS of -$0.60.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on ANRO
| Last price | $22.20 (-1.8%) |
|---|---|
| Normal 1-day range (±1σ) | ±3.8% |
| Earnings beat history | Beat the EPS estimate in 3 of the last 5 reports |
These figures come from the same calibrated model and valuation as the Alto Neuroscience stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Alto Neuroscience reports on Nov 11, 2026. One email the day before, with ATLAS’s read on Alto Neuroscience. You can switch it off at any time.
Alert me before ANRO reportsFree to start. Creating an account takes under a minute.
Notify me when Alto Neuroscience reports
Track ANRO free Add Alto Neuroscience to a free ATLAS watchlist and see its next report date in one place.
ANRO earnings at a glance
| Next report (confirmed) | Wed, Nov 11, 2026 |
|---|---|
| Time | After the close |
| Period | Quarter ended Sep 30, 2026 |
| EPS estimate | -$0.60 |
| Last report | Aug 12, 2026 · Beat |
| Beat rate (last 5 reports) | 3 of 5 (60%) |
| Average EPS surprise | -4.5% |
| Average move around a report | ±4.8% (last 5) |
| Sector | Healthcare · Biotechnology |
Alto Neuroscience earnings history: last 5 reports
Alto Neuroscience last reported on Aug 12, 2026: EPS of -$0.65 against an estimate of -$0.77 (+15.6% surprise), a beat.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Aug 12, 2026 | -$0.77 | -$0.65 | +15.6% | Beat | +12.2% |
| May 13, 2026 | -$0.50 | -$0.80 | -60.0% | Miss | -4.2% |
| Apr 17, 2026 | $1.00 | $1.09 | +9.0% | Beat | +4.9% |
| Mar 16, 2026 | -$0.51 | -$0.45 | +11.8% | Beat | +0.5% |
| Jan 20, 2026 | $0.88 | $0.89 | +1.1% | In line | +2.5% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for ANRO
See the fair value, the probability range and the earnings history of Alto Neuroscience on its ATLAS page.
Alto Neuroscience (ANRO) stock analysisPlans from €3.99 a month.
Alto Neuroscience earnings: frequently asked questions
When does Alto Neuroscience (ANRO) report earnings?
Alto Neuroscience is scheduled to report on Wednesday, November 11, 2026, after the close. ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
What is the EPS estimate for ANRO?
The consensus EPS estimate for the quarter ended Sep 30, 2026 is -$0.60 per share (USD). Estimates can change before the report.
How often does ANRO beat earnings estimates?
Of its last 5 reports with a recorded result, Alto Neuroscience beat the EPS estimate 3 times; the average surprise was -4.5%. Past results do not predict the next one.
How much does ANRO move around earnings?
Over its last 5 reports the stock moved an average of 4.8% (absolute, from the close before the report day to the close after it), and finished higher 4 of 5 times.
Did Alto Neuroscience beat earnings estimates last quarter?
Alto Neuroscience last reported on Aug 12, 2026: EPS of -$0.65 against an estimate of -$0.77 (+15.6% surprise), a beat.
How much does ANRO usually move in a day?
On a normal trading day the ATLAS model puts ANRO’s one-day range at about ±3.8%, with a 49% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Wed, Nov 11, 2026
Educational information, not investment advice. Disclaimer